Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21190996

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2011 Feb 24
First author
Miyawaki S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2011 Feb 24;117(8):2299-300. doi: 10.1182/blood-2011-01-328633.
    note
    Source null
    related pmid
    21350058
    relationship
    Comment in
  2. citation
    Acta Haematol. 2016;136(4):201-209. doi: 10.1159/000448209.
    note
    Source null
    related pmid
    27640088
    relationship
    Comment in

Authors and identifiers

  1. name
    Miyawaki S
    type
    Author
  2. name
    Ohtake S
    type
    Author
  3. name
    Fujisawa S
    type
    Author
  4. name
    Kiyoi H
    type
    Author
  5. name
    Shinagawa K
    type
    Author
  6. name
    Usui N
    type
    Author
  7. name
    Sakura T
    type
    Author
  8. name
    Miyamura K
    type
    Author
  9. name
    Nakaseko C
    type
    Author
  10. name
    Miyazaki Y
    type
    Author
  11. name
    Fujieda A
    type
    Author
  12. name
    Nagai T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Miyawaki S
    type
    Author
  2. name
    Ohtake S
    type
    Author
  3. name
    Fujisawa S
    type
    Author
  4. name
    Kiyoi H
    type
    Author
  5. name
    Shinagawa K
    type
    Author
  6. name
    Usui N
    type
    Author
  7. name
    Sakura T
    type
    Author
  8. name
    Miyamura K
    type
    Author
  9. name
    Nakaseko C
    type
    Author
  10. name
    Miyazaki Y
    type
    Author
  11. name
    Fujieda A
    type
    Author
  12. name
    Nagai T
    type
    Author
bibliography ids
  1. nci-bib-f5a78e328c4a4af16379f42f
book metadata
content sha256
91cc6c8b1e7df5f0bc5464d938392a5d267ef80ada47bc4c0ba01fedcdd6fc41
document type
citation
dois
  1. 10.1182/blood-2010-07-295279
electronic publication date
display
2010 Dec 29
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:21190996
immutable id
pubmed:21190996@91cc6c8b1e7df5f0bc5464d938392a5d267ef80ada47bc4c0ba01fedcdd6fc41
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
8
name
Blood
nlm unique id
7603509
pages
2366-72
volume
117
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2011 Feb 24;117(8):2299-300. doi: 10.1182/blood-2011-01-328633.
    note
    Source null
    related pmid
    21350058
    relationship
    Comment in
  2. citation
    Acta Haematol. 2016;136(4):201-209. doi: 10.1159/000448209.
    note
    Source null
    related pmid
    27640088
    relationship
    Comment in
outcomes validated
false
pmid
21190996
provenance
batch id
edef4b7f1a2a505cd5a9
provider
NCBI PubMed ESummary
record sha256
0d0747085059e80ff1cfd2abc869319bfacf98e3a5b401695659263d3ea237f6
response sha256
d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
retrieved at
2026-09-09T23:46:38.027615+00:00
publication date
display
2011 Feb 24
precision
day
year
2011
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21190996/
title
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.

Preserved source evidence · Not medical advice